Having trouble accessing articles? Reset your cache.

Aldeyra raises $25 million in follow-on

Aldeyra Therapeutics Inc. (NASDAQ:ALDX) raised $25 million through the sale of

Read the full 112 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE